Pemetrexed Fresenius 100 mg
Pemetrexed Fresenius 100 mg is a medicine authorised by Swissmedic under authorisation number 66595. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 24 January 2018 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 66595 |
|---|---|
| Name | Pemetrexed Fresenius 100 mg |
| Full name | Pemetrexed Fresenius 100 mg, Pulver zur Herstellung einer Infusionslösung |
| Authorisation holder | Fresenius Kabi (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | not stated |
| First authorisation | 24 January 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pemetrexed Fresenius 100 mg, Pulver zur Herstellung einer Infusionslösung | A | 24 January 2018 |
| 2 | Pemetrexed Fresenius 500 mg, Pulver zur Herstellung einer Infusionslösung | A | 24 January 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Pemetrexed Fresenius 100 mg authorised in Switzerland?
Yes. Pemetrexed Fresenius 100 mg is authorised by Swissmedic under authorisation number 66595, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Pemetrexed Fresenius 100 mg have?
Pemetrexed Fresenius 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Pemetrexed Fresenius 100 mg?
The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.